# US 2026/0306570 A1 · Production of a pharmaceutical dosage form from horseradish and nasturtium

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0306570 A1
- Document ID: US20260306570A1
- Status: Published application
- Kind: A1
- Application number: 19/483,059
- Filed: 2024-05-17
- Published: 2026-10-08
- Earliest claimed: 2023-05-17
- Assignees: Kwizda Pharma GmbH
- Applicants: Kwizda Pharma GmbH
- Inventors: Anja Witternigg; Silke Feichtinger; Wolfgang Reiss
- Web page: https://patentgrep.com/patent/US20260306570A1

## CPC

- A61K 36/31: Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K 9/4825: {Proteins, e.g. gelatin (gelatin capsule shells with substantial amounts of other macromolecular substances A61K9/4816)}
- A61K 9/4866: {Organic macromolecular compounds}
- A61K 2236/33: involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed is a method for producing a pharmaceutical dosage form, comprising the following steps: providing a dry extract component of horseradish (Armoracia rusticana) and nasturtium (Tropaeolum majus) with very low endogenous myrosinase activity; providing a dry drug component with horseradish root (Armoraciae rusticanae radix) and/or nasturtium herb (Tropaeoli maji herba); dry mixing the extract component with the drug component; and providing the mixture in the pharmaceutical dosage form. Also disclosed is a dosage form obtainable by this method.

## Claims

### Claim 1

A method for producing a pharmaceutical dosage form, comprising the following steps:
providing a dry extract component of horseradish (Armoracia rusticana) and nasturtium (Tropaeolum majus) with an endogenous myrosinase (EC 3.2.1.147) activity below 0.05 U/g, preferably below 0.01 U/g, in particular below 0.001 U/g;
providing a dry drug component with horseradish root (Armoraciae rusticanae radix) and/or nasturtium herb (Tropaeoli maji herba);
dry mixing the extract component with the drug component; and
providing the mixture in the pharmaceutical dosage form.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the drug component contains at least enough horseradish root and/or nasturtium herb with myrosinase activity that the mixture has a myrosinase activity of at least 0.01 U/g or even at least 0.05 U/g, preferably at least 0.1 U/g, more preferably at least 0.5 U/g, even more preferably at least 1.0 U/g.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the drug component includes horseradish root (Armoraciae rusticanae radix) and nasturtium herb (Tropaeoli maji herba).

### Claim 4 (depends on 1)

The method according to claim 1, wherein the extract component is a mixed extract of horseradish (Armoracia rusticana) and nasturtium (Tropaeolum majus), and optionally other plant constituents.

### Claim 5 (depends on 1)

The method according to claim 1, wherein providing the extract component comprises extracting with an extractant comprising an organic solvent, preferably alcohol, in particular methanol.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the extractant is at least 80% (v/v), preferably at least 90% (v/v), more preferably at least 95% (v/v), even more preferably at least 97.5% (v/v), in particular at least 98% (v/v) or even at least 99% (v/v) alcohol, preferably wherein the alcohol is methanol or ethanol.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the extract component and the drug component are obtained from the same plant parts.

### Claim 8 (depends on 1)

A pharmaceutical dosage form producible by the method according to claim 1.

### Claim 9

A pharmaceutical dosage form comprising:
an extract component of horseradish (Armoracia rusticana) and nasturtium (Tropaeolum majus); and
a drug component with horseradish root (Armoraciae rusticanae radix) and/or nasturtium herb (Tropaeoli maji herba);
Wherein the dosage form contains at least 1 mg glucosinolates.

### Claim 10 (depends on 8)

The pharmaceutical dosage form according to claim 8, wherein the dosage form has a myrosinase activity of at least 0.01 U/g or even at least 0.05 U/g, preferably at least 0.1 U/g, more preferably at least 0.5 U/g, even more preferably at least 1.0 U/g.

### Claim 11 (depends on 8)

The pharmaceutical dosage form according to claim 8, wherein the extract component and the drug component are present together in a powder mixture.

### Claim 12 (depends on 8)

The pharmaceutical dosage form according to claim 8, wherein the dosage form is a solid dosage form such as a capsule, tablet, or sachet.

### Claim 13 (depends on 8)

The pharmaceutical dosage form according to claim 8, wherein the dosage form contains at least 2 mg of glucosinolates.

### Claim 14 (depends on 8)

The pharmaceutical dosage form according to claim 8, wherein the dosage form forms at least 10 μg, preferably at least 20 μg, more preferably at least 40 μg, even more preferably at least 80 μg isothiocyanates in aqueous solution at pH 1 at 37° C. within 120 minutes.

### Claim 15 (depends on 8)

The pharmaceutical dosage form according to claim 8, wherein the extract component is an organic extract, preferably an alcoholic extract, in particular a methanolic or ethanolic extract.
